![bromo benzyl glutathione cyclopentyl diester S-p-Bromobenzylglutathione = 98 HPLC 166038-00-2 WO2018081211A1 - Deuterated 7-cyclopentyl-n, n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimdine-6-carboxamide](https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/structures/104/774/4d320ed2-8963-432d-9a10-c6d90667a973/640/4d320ed2-8963-432d-9a10-c6d90667a973.png)
bromo benzyl glutathione cyclopentyl diester S-p-Bromobenzylglutathione = 98 HPLC 166038-00-2 WO2018081211A1 - Deuterated 7-cyclopentyl-n, n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimdine-6-carboxamide
WO2018081211A1 Deuterated 7 cyclopentyl n, n dimethyl 2 ((5 (piperazin 1 yl)pyridin 2 yl)amino) 7h pyrrolo[2,3 d]pyrimdine 6 carboxamide Google Patents Anti cancer activity of cell permeable Glo1 inhibitor, Download Scientific Diagram Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes Oncotarget Growing Utilization of Radical Chemistry in the Synthesis of Pharmaceuticals Gupta 2023 The Chemical Record Wiley Online Library Metabolic drivers of genome instability in cancer: mechanisms and therapeutic opportunities Experimental Hematology & Oncology Springer Nature Link
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
![bromo benzyl glutathione cyclopentyl diester S-p-Bromobenzylglutathione = 98 HPLC 166038-00-2 WO2018081211A1 - Deuterated 7-cyclopentyl-n, n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimdine-6-carboxamide](https://patentimages.storage.googleapis.com/c1/b7/7e/9e3dcf9c37ccc9/imgf000040_0001.png)
![bromo benzyl glutathione cyclopentyl diester S-p-Bromobenzylglutathione = 98 HPLC 166038-00-2 WO2018081211A1 - Deuterated 7-cyclopentyl-n, n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimdine-6-carboxamide](https://www.researchgate.net/publication/358819012/figure/tbl1/AS:1132418622861313@1647001047382/Anti-cancer-activity-of-cell-permeable-Glo1-inhibitor-S-p-bromobenzylglutathione-cy.png)
![bromo benzyl glutathione cyclopentyl diester S-p-Bromobenzylglutathione = 98 HPLC 166038-00-2 WO2018081211A1 - Deuterated 7-cyclopentyl-n, n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimdine-6-carboxamide](https://www.oncotarget.com/social-image/article/2121/figure/23213/2121-23213-1-PB.jpg)
![bromo benzyl glutathione cyclopentyl diester S-p-Bromobenzylglutathione = 98 HPLC 166038-00-2 WO2018081211A1 - Deuterated 7-cyclopentyl-n, n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimdine-6-carboxamide](https://onlinelibrary.wiley.com/cms/asset/3e4fe4cb-3a29-44bc-b652-5eac37e6b7e1/tcr202300207-fig-5071-m.png)
![bromo benzyl glutathione cyclopentyl diester S-p-Bromobenzylglutathione = 98 HPLC 166038-00-2 WO2018081211A1 - Deuterated 7-cyclopentyl-n, n-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7h-pyrrolo[2,3-d]pyrimdine-6-carboxamide](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40164-026-00775-3/MediaObjects/40164_2026_775_Fig1_HTML.png)